HARROW HEALTH, INC. License Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License Agreement, dated July 29, 2019, among Stowe Pharmaceuticals, Inc., TGV-Health, LLC and TGV-Ophthalnix, LLC
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2019
Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2024
Second Amendment to License and Supply Agreement, dated August 4, 2023, between Harrow IP, LLC and Sintetica S.A
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
2023
License Agreement, dated as of August 18, 2021, by and between the Company and Wakamoto Pharmaceutical Co., Ltd
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
License and Supply Agreement, dated as of July 25, 2021, by and between the Company and Sintetica, S.A
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
NY
2021
License Agreement, dated July 28, 2019, among Mayfield Pharmaceuticals, Inc., TGV-Health, LLC and TGV-Gyneconix, LLC
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
DE
2019
Amended and Restated License Agreement dated April 10, 2018 between Imprimis Pharmaceuticals, Inc. and Richard L. Lindstrom, M.D
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2018
ASSETPURCHASE AND LICENSE AGREEMENT
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
ASSETPURCHASE AND LICENSE AGREEMENT
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2017
License Agreement, dated as of August 30, 2012, by and between Imprimis Pharmaceuticals, Inc. and Professional Compounding Centers of America, Inc
License Agreements
HARROW HEALTH, INC.
Pharmaceuticals
CA
2012